首页> 外国专利> TUMOR SUPPRESSOR LKB1 KINASE DIRECTLY ACTIVATES AMP-ACTIVATED KINASE

TUMOR SUPPRESSOR LKB1 KINASE DIRECTLY ACTIVATES AMP-ACTIVATED KINASE

机译：肿瘤抑制因子LKB1激酶直接激活AMP激活的激酶

页面导航

摘要
著录项
相似文献

摘要

The invention relates to modulation of LKB1 or AMP kinase protein activity for treating disorders including diabetes and cancer. The invention also relates to screening for agents that modulate the activity of LKB1 or AMP kinase protein, which are useful in the treatment of diabetes and cancer, as well as preparing compounds for treatment of diabetes and cancer.

机译：本发明涉及用于治疗包括糖尿病和癌症的疾病的LKB1或AMP激酶蛋白活性的调节。本发明还涉及筛选调节LKB1或AMP激酶蛋白活性的试剂，其可用于治疗糖尿病和癌症，以及制备用于治疗糖尿病和癌症的化合物。

著录项

公开/公告号WO2005023202A2

专利类型
公开/公告日2005-03-17

原文格式PDF
申请/专利权人 BETH ISRAEL DEACONESS MEDICAL CENTER INC.;DANA-FARBER CANCER INSTITUTE INC.;CANTLEY LEWIS C.;SHAW REUBEN J.;BARDEESY NABEEL;DEPINHO RONALD A.;
展开▼

申请/专利号WO2004US29437
发明设计人 CANTLEY LEWIS C.;SHAW REUBEN J.;BARDEESY NABEEL;DEPINHO RONALD A.;
展开▼

申请日2004-09-09
分类号A61K;
国家 WO
入库时间 2022-08-21 22:11:09

相似文献

专利
外文文献
中文文献